ImmunOs Therapeutics

Switzerland
Schlieren, Zurich, Switzerland, 8952

Company profile

ImmunOs Therapeutics company profile

ImmunOs Therapeutics AG is a clinical-stage biotechnology company focused on discovering and developing next generation and novel human immunomodulatory proteins with a role in both innate and adaptive immunity.Their mission is to develop the next generation of novel therapeutics that will improve the lives of patients with serious disease.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
8952
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
7
Total equity funding
$101.8M
Last funding
Series C / $11M / 2024-09-17
Last equity funding
Series C / $11M
Investors
20
Lead investors
7
Founders
1
Articles
23

Founders and investors

Founders

Osiris Marroquin Belaunzaran

Lead investors

BioMedPartnersDouble Point VenturesGimvLightspeed Venture PartnersMiklos StanekPfizer Venture InvestmentsSamsara BioCapital

Investors

European UnionLightspeed Venture PartnersMission BioCapitalPfizer Venture InvestmentsSamsara BioCapital